Skip to main content
Tuesday
May 06, 2025
Sign In
Subscribe
Epaper
Economy
Aviation
Banking
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
Videos
TBS Today
TBS Stories
TBS World
News of the day
TBS Programs
Podcast
Editor's Pick
World+Biz
Features
Panorama
The Big Picture
Pursuit
Habitat
Thoughts
Splash
Mode
Tech
Explorer
Brands
In Focus
Book Review
Earth
Food
Luxury
Wheels
Subscribe
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Bangladesh
Supplement
Infograph
Archive
Gallery
Long Read
Interviews
Offbeat
Magazine
Climate Change
Health
Cartoons
বাংলা
TUESDAY,
MAY 06, 2025
GSK
World+Biz
GSK licenses companies to make cheap copies of HIV prevention drug
World+Biz
Unilever CEO set to leave after GSK debacle, arrival of activist investor
Coronavirus chronicle
Healthcare companies Sanofi and GSK to seek Covid-19 vaccine regulatory approval
Global Economy
Unilever's offer for GSK's consumer health raises doubts, questions over strategy
Global Economy
Unilever says it wants to buy GSK's consumer goods arm
Coronavirus chronicle
New data shows GSK-Vir drug works against all Omicron mutations
Coronavirus chronicle
UK approves GSK Covid drug, appears effective against Omicron
Coronavirus chronicle
GSK says tests show antibody drug works against Omicron
Health
GSK to develop longer-acting therapy for HIV with Japan's Shionogi
Coronavirus chronicle
Study confirms GSK-Vir antibody drug reduces hospitalisation, death in Covid-19 patients
World+Biz
GSK fires former US govt vaccine head Slaoui over harassment allegation
Coronavirus chronicle
GSK, Sanofi begin new Covid-19 vaccine trial of protein-based vaccine
Coronavirus chronicle
GSK, Vir Biotech to expand Covid -19 research partnership for other diseases
Show More